AC Immune SA - Company Profile
Powered by 
All the data and insights you need on AC Immune SA in one report.
$295
- Save hours of research time and resources with
our up-to-date AC Immune SA Strategy Report
- Understand AC Immune SA position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on AC Immune SA’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 15 Dec 2023 | AC Immune Prices USD50.05 Million in Public Offering of Securities | Equity Offering |
BVF Partners LP
Avidity Partners LLC
StemPoint Capital LP
Redmile Group LLC
|
AC Immune SA |
| 21 Jun 2022 | AC Immune SA Enters Phase I/II Clinical Trial Agreement with Worldwide Clinical Trials Holdings Inc for ACI-24060 (GDCT0446728) | Contract Service Agreement |
AC Immune SA
|
Worldwide Clinical Trials Holdings Inc
|
| 27 Jul 2021 | AC Immune Raises USD25 Million in Private Placement | Private Equity |
MIG Capital AG
First Capital Partner GmbH
ATHOS Service GmbH
|
AC Immune SA |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer